View the latest articles from the Lhasa blog
Using existing data better and relying less on animal testing
I recently read that by 2025, 36% of world data will be healthcare data. (Yes, thirty-six percent!). Considering this statistic, now more than ever, it is important that we are working to ensure existing data is utilised to make better safety assessment decisions more quickly - whilst also relying less on animal testing.
04 August 2022
5 things you should know about the data in the Lhasa Carcinogenicity Database (LCDB)
5 minute read
25 May 2022
Is expert review an essential step when assessing mutagenic potential of drug impurities?
less than 5 minute read
05 May 2022
Controlling potentially mutagenic impurities – 8 top tips from industry experts
less than 5 minute read
04 April 2022
Most popular
20 tips for nitrosamine impurity assessment
05 August 2021
The top 5 benefits of data sharing with Vitic [an infographic]
08 April 2021
Lhasa Limited supports the global challenge of nitrosamine impurity assessment
13 July 2020